Hong Kong healthcare sector hits $3.4t market cap as of June

This is three times the $1.12b (US$144b) recorded at the end of 2017.

As of June, the total market capitalisation of the Hong Kong-listed healthcare sector stood at $3.4t (US$441b), accounting for 8.1% of the total market cap of Hong Kong-listed companies, according to an HKTDC Research report.

The figure is three times the $1.12b (US$144b) recorded at the end of 2017, before the launch of the HKEX Chapter 18A regime.

Meanwhile, 73 companies have gone public since the listing rules came into effect, collectively raising $124.5b (US$16b).

The sector surged by around 30% in the last decade, with the total number of related businesses now exceeding 3,000.

Hong Kong-based biotech and healthtech start-ups more than quadrupled, rising from 110 in 2018 to 510 in 2024, while the sector’s share of the city’s total start-up ecosystem increased from 4% to 11%.

Key areas include drug development, gene editing technology, medical device innovation and precision medical solutions.

US$1 = $7.78